Sun Pharmaceutical Industries Ltd. has joined a flock of Indian firms putting the pedal to the metal in China amid evolving regulations and emerging opportunities for growth in the world’s second largest pharmaceutical market.
China Ho! Sun Strikes Deals For Ilumya, Cequa
India's Sun has licensed out treatments for psoriasis and dry eye to a new partner for selected Asian markets and China, which it expects to emerge as a key market for its products.
